Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1100 of 2529 entries
View as:

Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00446511 Org: User:
Start: 06/30/07 End: 06/30/09 Due: 06/30/10

Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00110240 Org: User:
Start: 04/30/05 End: 10/31/06 Due: 10/31/07

Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

Phase: N/A Priority: Normal
NCT ID: NCT01958918 Org: User:
Start: 10/23/13 End: 05/29/17 Due: 05/29/18

Dose Escalation Study of Pasireotide (SOM230) in Patients With Advanced Neuroendocrine Tumors (NETs)

Phase: N/A Priority: Normal
NCT ID: NCT01364415 Org: User:
Start: 08/31/11 End: 04/30/16 Due: 04/30/17

Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03822468 Org: User:
Start: 06/11/19 End: 08/30/24 Due: 08/30/25

Specified Drug-use Surveillance of Fabhalta Capsules

Phase: N/A Priority: Normal
NCT ID: NCT06606314 Org: User:
Start: 09/18/24 End: 09/30/28 Due: 09/30/29

A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT07032272 Org: User:
Start: 06/27/25 End: 11/29/25 Due: 11/29/26

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT06894511 Org: User:
Start: 08/29/25 End: 04/09/29 Due: 04/09/30

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04925479 Org: User:
Start: 12/27/21 End: 11/01/31 Due: 11/01/32

A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence

Phase: N/A Priority: Normal
NCT ID: NCT06830720 Org: User:
Start: 02/20/25 End: 05/31/30 Due: 05/31/31

Healthcare Costs and Resource Utilization in Aimovig Migraine Patients: a Retrospective Study Using United States Claims Data

Phase: N/A Priority: Normal
NCT ID: NCT05177406 Org: User:
Start: 08/31/20 End: 12/31/20 Due: 12/31/21

Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00170833 Org: User:
Start: 11/30/03 End: - Due: -

Terbinafine Compared to Griseofulvin in Children With Tinea Capitis

Phase: N/A Priority: Normal
NCT ID: NCT00117767 Org: User:
Start: 06/30/04 End: - Due: -

Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03299686 Org: User:
Start: 11/06/17 End: 07/08/19 Due: 07/08/20

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00699192 Org: User:
Start: 05/31/08 End: 05/31/09 Due: 05/31/10

Study of Efficacy and Safety of LDE225 in Adult Patients With Relapsed/Refractory Acute Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01826214 Org: User:
Start: 05/31/13 End: 05/31/15 Due: 05/31/16

Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00377962 Org: User:
Start: 12/31/05 End: 02/28/10 Due: 02/28/11

Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers

Phase: N/A Priority: Normal
NCT ID: NCT01460849 Org: User:
Start: 03/31/11 End: 03/31/11 Due: 03/31/12

Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT04882124 Org: User:
Start: 09/24/21 End: 09/15/22 Due: 09/15/23

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01110889 Org: User:
Start: 05/31/10 End: - Due: -

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Phase: N/A Priority: Normal
NCT ID: NCT00303329 Org: User:
Start: 03/31/04 End: 10/31/08 Due: 10/31/09

Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT00172003 Org: User:
Start: 09/30/04 End: 07/31/09 Due: 07/31/10

16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT01948791 Org: User:
Start: 08/31/14 End: 09/30/15 Due: 09/30/16

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

Phase: N/A Priority: Normal
NCT ID: NCT03481634 Org: User:
Start: 07/23/18 End: 10/18/21 Due: 10/18/22

Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib.

Phase: N/A Priority: Normal
NCT ID: NCT01289028 Org: User:
Start: 11/30/08 End: 07/31/14 Due: 07/31/15